Data / Form D filings / Entact Bio, Inc.
Entact Bio, Inc.: Form D filings
Entact Bio, Inc., a biotechnology company in Watertown, MA, filed 3 Form D notices with the SEC between 2024 and 2026. The latest, on June 3, 2026, reports $10 million sold of a $10 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 65 Grove Street, Suite 303, Watertown, MA, 02472
- Phone
- (617) 909-7579
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2008244
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | New notice | $9,999,997 | $9,999,997 | 7 | Jan 8, 2026 | sec.gov | |
| May 15, 2024 | Amendment | $40,321,700 | $40,321,700 | 7 | Jan 19, 2024 | sec.gov | |
| Jan 31, 2024 | New notice | $39,899,999 | $39,899,999 | 6 | Jan 19, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Victoria Richon | Executive Officer, Director, Promoter | |
| Owen Smith | Director | |
| Pini Orbach | Director | |
| Andrew Sinclair | Director | |
| Richard Gaster | Director | |
| Anna French | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jun 1, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Entact Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.